Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Surgical Pathology Clinics|November 2, 2019
Treatment of Differentiated Thyroid CarcinomasMelissa G Lechner, Stephanie Smooke Praw, Trevor E Angell
The Oncologist|September 1, 2020
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-AnalysisMelissa G Lechner, Angeli C Bernardo, Alyssa Lampe, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2022
Approach to the Patient With a Suppressed TSHStephanie Smooke Praw, Gregory A Brent
International Journal of General Medicine|April 3, 2010
Medical treatment of Cushing's disease: Overview and recent findingsStephanie Smooke Praw, Anthony P Heaney
Current Opinion in Endocrinology, Diabetes, and Obesity|August 2, 2023
Molecular testing for indeterminate thyroid nodules: past, present, and futureRajam Raghunathan, Stephanie Smooke Praw, Masha Livhits
AACE Clinical Case Reports|September 22, 2023
Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced ThyroiditisDennis H Chen, Heinz-Josef Lenz, Melissa G Lechner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Thyroid : Official Journal of the American Thyroid Association|October 31, 2025
Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerStephanie Smooke Praw, Benjamin J Gigliotti, Alex Tessnow, et al.
Surgery|November 19, 2013
Effect of reoperation on outcomes in papillary thyroid cancerStephanie Young, Avital Harari, Stephanie Smooke-Praw, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2014
BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltrationTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Pageof 12